World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
22046
World Ranking
2047
National Ranking
79

Overview

Kyogo Itoh is affiliated with Kurume University in Japan and focuses their research primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Surgery.

The scientist has contributed extensively to topics related to Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Prostate Cancer Treatment and Research, Colorectal and Anal Carcinomas, Colorectal Cancer Treatments and Studies, as well as Peptidase Inhibition and Analysis.

Kyogo Itoh's recent publications include the following papers:

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer, 2020, Journal of Clinical Oncology
  • A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel, 2020, Oncology Reports
  • Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial, 2020, Cancer Immunology Immunotherapy
  • Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer, 2020, Cancer Science
  • Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients, 2020, International Journal of Oncology

The scientist frequently publishes in journals such as Molecular and Clinical Oncology, Journal of Clinical Oncology, Oncology Reports, Cancer Immunology Immunotherapy, and Cancer Science.

Collaborations form an important aspect of their research. Kyogo Itoh often works with coauthors including:

  • Shigeki Shichijo
  • Akira Yamada
  • Uhi Toh
  • Masanori Noguchi
  • Shigetaka Suekane

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

    T. Higuchi;N. Seki;S. Kamizono;A. Yamada

  • Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

    Kyogo Itoh;Chris D. Platsoucas;Charles M. Balch

  • A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes

    Shigeki Shichijo;Masanobu Nakao;Yasuhisa Imai;Hideo Takasu

  • Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis.

    Koichi Takahashi;Shigeki Shichijo;Masanori Noguchi;Masaru Hirohata

  • Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity

    Shigeki Kataoka;Jo Satoh;Hiroshi Fujiya;Takayoshi Toyota

  • Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

    Charles M. Balch;Lee B. Riley;Yoon Joo Bae;Marie A. Salmeron

  • Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.

    Damu Yang;Masanobu Nakao;Shigeki Shichijo;Teruo Sasatomi

  • Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

    Yukiko Ohyama;Seiji Nakamura;Goro Matsuzaki;Masanori Shinohara

  • Lichen planus and hepatitis C virus in the northern Kyushu region of Japan

    Y Nagao;M Sata;K Tanikawa;K Itoh

  • Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.

    Sunao Sugita;Hiroshi Takase;Chikako Taguchi;Yasuhisa Imai

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

    Bernhard Mlecnik;Carlo Bifulco;Gabriela Bindea;Gabriela Bindea;Florence Marliot

  • Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.

    Masanobu Nakao;Shigeki Shichijo;Toshihiro Imaizumi;Yoshiko Inoue

  • Next‐generation peptide vaccines for advanced cancer

    Akira Yamada;Tetsuro Sasada;Masanori Noguchi;Kyogo Itoh

  • Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

    Naoki Yajima;Ryuya Yamanaka;Takashi Mine;Naoto Tsuchiya

  • Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.

    Tetsuya Nakatsura;Tetsuya Nakatsura;Satoru Senju;Masaaki Ito;Yasuharu Nishimura

  • Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation.

    Unknown

  • Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.

    Masanori Noguchi;Kazuhiko Kobayashi;Norie Suetsugu;Katsurou Tomiyasu

  • Induction of Cellular Immune Responses to Tumor Cells and Peptides in Colorectal Cancer Patients by Vaccination with SART3 Peptides

    Yoshiaki Miyagi;Nobue Imai;Teruo Sasatomi;Akira Yamada

  • Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes.

    Megumi Kikuchi;Masanobu Nakao;Yoshiko Inoue;Kazuko Matsunaga

  • Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

    Takashi Mine;Yuji Sato;Masanori Noguchi;Teruo Sasatomi

Frequent Co-Authors

Akira Yamada
Akira Yamada Kurume University
Michio Sata
Michio Sata Kurume University
Satoru Todo
Satoru Todo Hokkaido University
Manabu Mochizuki
Manabu Mochizuki Tokyo Medical and Dental University
Seiji Naito
Seiji Naito Kyushu University
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Akinori Kimura
Akinori Kimura Tokyo Medical and Dental University
Noriyuki Sato
Noriyuki Sato Sapporo Medical University
Toshihiko Torigoe
Toshihiko Torigoe Sapporo Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing a related nursing degree can open diverse career opportunities in healthcare and research. Many professionals choose to advance their education through an accelerated nurse practitioner program, which provides a faster track to becoming a nurse practitioner with strong clinical skills applicable in immunology-focused medical settings.

Those transitioning from general nursing roles may explore acute care nurse practitioner certification to specialize in treating patients with complex immune-related conditions. This certification builds expertise for managing acute illnesses and contributes valuable knowledge to immunology-based healthcare teams.

For individuals without a nursing background, programs like the best online RN programs for non nurses provide flexible pathways into nursing careers. These programs help non-nurses gain essential clinical foundations that support further specialization in immunological research or patient care.

Additionally, many aspiring nurses begin with the easiest ABSN programs to get into, enabling quicker entry into the nursing field. From there, they can pursue advanced credentials to bridge nursing with immunology expertise, expanding career opportunities.

Best Scientists Citing Kyogo Itoh

Trending Scientists